Clinical Research Directory
Browse clinical research sites, groups, and studies.
Application of ihMT MRI in Multiple Sclerosis
Sponsor: Assistance Publique Hopitaux De Marseille
Summary
The development of in vivo biomarkers sensitive to myelin disruption represents a major clinical need to be able to monitor the demyelination processes as well as the effect of remyelinating therapies in multiple sclerosis. The investigators recently proposed a technique, derived from the conventional magnetisation transfer (MT): inhomogeneous Magnetisation Transfer (ihMT). In preliminary studies, this simple-to-implement and robust technique has shown great sensitivity for evaluating the demyelination processes. The goal of the project is to evaluate the ability of ihMT to measure and describe the spontaneous demyelination and remyelination processes involved in active lesions in a population of patients with MS at the the disease onset.
Official title: Application of the Inhomogeneous Magnetisation Transfer MRI (ihMT) Technique, a New Myelin-specific MRI Technique, in Multiple Sclerosis
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
85
Start Date
2018-06-14
Completion Date
2027-02-13
Last Updated
2024-08-06
Healthy Volunteers
Yes
Conditions
Interventions
inhomogeneous Magnetisation Transfer (ihMT) sequence
robust technique has shown great sensitivity for evaluating the demyelination processes using MRI at 1.5T
inhomogeneous Magnetisation Transfer (ihMT) sequence at 3T
robust technique has shown great sensitivity for evaluating the demyelination processes using MRI at 3T
Locations (1)
Assistance Publique Des Hotipaux de Marseille
Marseille, PACA, France